During the past decade, S.C. Cardiomed S.R.L. conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 5 clinical trials were completed, i.e. on average, 83.3% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 5 clinical trials were completed. i.e. 250% of trials that started reached the finish line.

Out of the total clinical trials conducted in "S.C. Cardiomed S.R.L." #1 sponsor was "Actelion" with 2 trials, followed by "Boehringer Ingelheim" with 2 trials sponsored, "Amgen" with 1 trials sponsored, "Bayer" with 1 trials sponsored and "Cogentus Pharmaceuticals" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "S.C. Cardiomed S.R.L." #1 collaborator was "AcitGraph" with 1 trials as a collaborator, "Almac Clinical Technologies, LLC" with 1 trials as a collaborator, "Chiltern International Ltd." with 1 trials as a collaborator, "Covance Central Laboratory Services, LP" with 1 trials as a collaborator and "Eli Lilly and Company" with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "S.C. Cardiomed S.R.L." are "Atrial Fibrillation" (2 trials), "Acute Coronary Syndrome" (1 trials), "Coronary Artery Disease" (1 trials), "Coronary Heart Disease (CHD)" (1 trials) and "Gout" (1 trials). Many other conditions were trialed in "S.C. Cardiomed S.R.L." in a lesser frequency.

Most popular intervention types in "S.C. Cardiomed S.R.L." are "Drug" (7 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Allopurinol 100 up to 600mg/day" (1 trials), "Apixaban" (1 trials), "Apixaban matching placebo" (1 trials) and "Asundexian (BAY2433334)" (1 trials). Other intervention names were less common.

The vast majority of trials in "S.C. Cardiomed S.R.L." are 8 trials for "All" genders.

Currently, there are NaN active trials in "S.C. Cardiomed S.R.L.". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 4 completed trials in S.C. Cardiomed S.R.L., undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in S.C. Cardiomed S.R.L., 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".